How has been the historical performance of Ajooni Biotech?

Answer:The historical performance of Ajooni Biotech shows significant growth in net sales and profitability over the years, particularly from March 2021 to March 2025.

Breakdown:
Ajooni Biotech's net sales have increased from 51.04 crore in March 2021 to 114.69 crore in March 2025, reflecting a strong upward trend. Total operating income has similarly risen, reaching 114.69 crore in March 2025, compared to 51.06 crore in March 2021. The company's total expenditure has also grown, amounting to 111.01 crore in March 2025, up from 49.39 crore in March 2021. Operating profit, excluding other income, has improved from 1.67 crore in March 2021 to 3.68 crore in March 2025, while profit before tax has increased from 0.50 crore to 4.33 crore over the same period. Profit after tax has shown a notable rise, reaching 3.37 crore in March 2025, compared to 0.37 crore in March 2021. The company's total assets have expanded significantly from 27.88 crore in March 2021 to 94.67 crore in March 2025, while total liabilities have increased from 27.88 crore to 94.67 crore during the same timeframe. Cash flow from operating activities has been negative in March 2025 at -17.00 crore, contrasting with a positive cash flow of 22.00 crore in March 2024. Overall, Ajooni Biotech has demonstrated robust growth in sales and profitability, despite some fluctuations in cash flow.